Connexins in Cancer: Bridging the Gap to the Clinic. Oncogene. Volume 38, 4429–4451 (2019). Abstract Impact factor 6.933 (Q1)
EU-COST Actions: fostering international and national collaborative research for rare diseases. The Lancet Neurology. Correspondence. Vol 18, November 2019, 989-991. Fulltext. Impact factor 28.755 (D1).
New Therapeutic Strategies for Osteoarthritis by Targeting Sialic Acid Receptors. Biomolecules 2020, 10(4), 637; https://doi.org/10.3390/biom10040637. Fulltext. Impact factor 4.694 (Q1)
Emerging functions and clinical prospects of connexins and pannexins in melanoma. BBA Reviews on Cancer. Available online 24 May 2020. Fulltext. Impact factor 6.887 (D1)
Senolytic activity of small molecular polyphenols from olive restores chondrocyte redifferentiation and promotes a pro-regenerative environment in osteoarthritis. Aging. Manuscript accepted 14 July 2020. Impact factor 5.515 (Q1)(D1)
Paula Carpintero-Fernandez, Raquel Gago-Fuentes, Hong Z. Wang, Eduardo Fonseca, Jose R. Caeiro, Virginijus Valiunas, Peter R. Brink and Maria D. Mayan*.
Intercellular communication via gap junction channels between chondrocytes and bone cells. Biochimica et Biophysica Acta (BBA) – Biomembranes. Volume 1860, Issue 12, December 2018, Pages 2499-2505. Abstract Impact factor 3.79 (Q1)pact factor 6.933 (Q1)
Marta Varela-Eirin, Jesus Loureiro, Eduardo Fonseca, Silvia Corrochano, Jose R. Caeiro, Manuel Collado and Maria D. Mayan*.
Cartilage regeneration and ageing: Targeting cellular plasticity in osteoarthritis. Ageing Research Reviews. 2018 Mar;42:56-71. doi: 10.1016/j.arr.2017.12.006. Epub 2017 Dec 16. Abstract Impact factor 10.39 (D1)
Targeting of chondrocyte plasticity via connexin43 modulation attenuates cellular senescence and fosters a pro-regenerative environment in osteoarthritis. Cell Death and Disease. 2018 Dec 5;9(12):1166. doi: 10.1038/s41419-018-1225-2. Abstract. Impact factor 6.187 (Q1)
Marta Varela-Eirin; Adrian Varela-Vazquez; Marina Rodriguez-Candela Mateos; Anton Vila-Sanjurjo; Eduardo Fonseca; Jose Luis Mascareñas; Eugenio Vazquez; Maria D. Mayan*.
Recruitment of RNA molecules by connexin RNA-binding motifs: implication in RNA and DNA transport through microvesicles and exosomes. BBA – Molecular Cell Research. Volume 1864, Issue 4, April 2017, Pages 728–736. Full Text. Impact factor 5.282 (Q1)
Angel Fernandez-Flores*, Adrian Varela, María D. Mayan, Eduardo Fonseca.
Expression of connexin43 (Cx43) in the human hair follicle: emphasis on the Cx43 protein levels in the bulge and through the keratinisation process. Journal of Cutaneous Pathology. 2017 Sep 28. doi: 10.1111/cup.13050. Impact factor 1.409 (Q3)
The C-terminal domain of connexin43 modulates cartilage structure via chondrocyte phenotypic changes. Oncotarget. Nov 8;7(45):73055-73067. doi: 10.18632/oncotarget. 12197. Full text Impact factor 6.359 (D1)
Connexins and pannexins as new therapeutic targets and diagnostic biomarkers for skin diseases. Piel. Elsevier 2016;31:254-62 – DOI: 10.1016/j.piel.2015.09.011
Proteomic analysis of connexin 43 reveals novel interactors related to osteoarthritis. Molecular & Cellular Proteomics. First Published on April 22, 2015, doi: 10.1074/mcp.M115.050211. [Full text] Impact factor 6.564 (D1)
Global H3K9 Hypo-Acetylation and Promoter-Specific Hyper-Acetylation Facilitate E2F1-Mediated FOS Induction in Arsenic Trioxide Induced Cellular Transformation. Environmental Health Perspectives. 2015 May;123(5):484-92. doi: 10.1289/ehp.1408302. Epub 2015 Jan 9. Impact factor 7.977 (D1)
Biochemical evidence for gap junctions and Cx43 expression in immortalized human chondrocyte cell line: a potential model in the study of cell communication in human chondrocytes. Osteoarthritis and Cartilage. 2014 Feb 13. pii: S1063-4584(14)00041-7. doi: 10.1016/j.joca.2014.02.002. [ABSTRACT] Impact factor 4.165 (D1)
Human Articular Chondrocytes Express Multiple Gap Junction Proteins: Differential Expression of Connexins in Normal and Osteoarthritic Cartilage. Am J Pathol. 2013 Apr;182(4):1337-46.[ABSTRACT] Impact factor 4.591 (Q1)
RNAP-II transcribes two small RNAs at the promoter and terminator regions of the RNAP-I gene in Saccharomyces cerevisiae. Yeast. 2013 Jan;30(1):25-32. [ABSTRACT] Impact factor 1.634 (Q2)
Cdc14 phosphatase promotes segregation of telomeres through repression of RNA polymerase II transcription. Nature Cell Biology, 2011 13, 1450-1456. [ABSTRACT] Impact factor 19.679 (D1)
Cis-interactions between non-coding ribosomal spacers dependent on RNAP-II separate RNAP-I and RNAP-III transcription domains. Cell Cycle 9:21, 4328-4337; November 1, 2010.[ABSTRACT] Impact factor 4.565 (Q2)
(2009). Cdc14 inhibits transcription by RNA polymerase I during anaphase. Nature, 2009 458, 219-222 (12 March 2009). [ABSTRACT] Impact factor 41.456 (D1)
A redundancy of processes that cause replication fork stalling enhances recombination at two distinct sites in yeast rDNA. Molecular Microbiology, 2008. Jul; 69 (2): 361-75. [ABSTRACT] Impact factor 4.419 (Q1)
Plasma albumin concentration is a predictor of HbA1c among type 2 diabetic patients, independently of fasting plasma glucose and fructosamine. Diabetes Care. 2005 Feb; 28(2):437-9. [ABSTRACT] Impact factor 8.420 (D1)